Exeter-based university spin-out Senisca Ltd has added £3.7m seed money to a £1.1m not dilutive funding to...
Up To Date
Latest News
French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca.
London-based virtual drug discovery specialist Relation Therapeutics Ltd has closed another US$35m seed...
TREM2, a receptor on the surface of macrophages, reduces necrotic core formation in early atherosclerosis, a...
British companies Arecor Therapeutics plc and TRx Biosciences Ltd combine their technologies to formulate an...
German researchers for the first time have expanded the half life of oligonucleotide-based drugs using...